Genetic determinants of virulence in the group B coxsackieviruses

被引:2
|
作者
Kim, Kisoon [1 ]
Kanno, Toru [1 ]
Chapman, Nora M. [1 ]
Tracy, Steven [1 ]
机构
[1] Univ Nebraska Med Ctr, Coll Nursing, Dept Pathol & Microbiol, Omaha, NE 68198 USA
关键词
enterovirus; genetics of virulence; group B coxsackievirus; persistence; picornavirus;
D O I
10.2217/17460794.1.5.597
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The group B coxsackleviruses (CVB) are well-studied human enteroviruses that are established causes of numerous serious human diseases. Characterized differences in CVB genomes of different strains affect the ability with which specific strains induce disease in the mouse host and, by inference, in humans as well. The first hurdle is to define specific examples of CVB genetic changes that are associated with pathogenic phenotypes. Such differences have been mapped both to coding and noncoding genomic regions. Many studies have used laboratory-derived strains to identify genetic differences that are essential to phenotype expression, work that is valuable but requires confirmation from studies of wild-type isolates. Rapid viral replication is closely associated with acute disease, indicating a key role for viral damage to the host, while host-mediated responses to the viral infection and viral persistence over a longer period of time indicate other roles for the virus in pathogenesis.
引用
收藏
页码:597 / 604
页数:8
相关论文
共 50 条
  • [1] Genetic divergence among the group B coxsackieviruses
    Romero, JR
    Price, C
    Dunn, JJ
    COXSACKIE B VIRUSES, 1997, 223 : 97 - 152
  • [2] The group B coxsackieviruses and myocarditis
    Kim, KS
    Hufnagel, G
    Chapman, NM
    Tracy, S
    REVIEWS IN MEDICAL VIROLOGY, 2001, 11 (06) : 355 - 368
  • [3] Vaccines against Group B Coxsackieviruses and Their Importance
    Mone, Kiruthiga
    Lasrado, Ninaad
    Sur, Meghna
    Reddy, Jay
    VACCINES, 2023, 11 (02)
  • [4] Receptor for the group B coxsackieviruses and adenoviruses: CAR
    Carson, SD
    REVIEWS IN MEDICAL VIROLOGY, 2001, 11 (04) : 219 - 226
  • [5] GROUP-B COXSACKIEVIRUSES AS RESPIRATORY VIRUSES
    HABLE, KA
    OCONNELL, EJ
    HERRMANN, EC
    MAYO CLINIC PROCEEDINGS, 1970, 45 (03) : 170 - &
  • [6] DETERMINATION OF PATHOGENIC POTENTIAL IN EMERGING GROUP B COXSACKIEVIRUSES
    Quinn, K.
    Wollersheim, S.
    Zuo, J.
    Cooper, P.
    Krogstad, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (01) : 230 - 230
  • [7] Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes
    Sane, Famara
    Moumna, Ilham
    Hober, Didier
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 357 - 366
  • [8] Seroprevalence of group B Coxsackieviruses: Retrospective study in an Italian population
    Sciandra, Ilaria
    Falasca, Francesca
    Maida, Paola
    Tranquilli, Giulia
    Di Carlo, Daniele
    Mazzuti, Laura
    Melengu, Taulant
    Giannelli, Gianluigi
    Antonelli, Guido
    Turriziani, Ombretta
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (12) : 3138 - 3143
  • [9] Genetic determinants of virulence - Candida parapsilosis
    Singaravelu, Kumara
    Gacser, Attila
    Nosanchuk, Joshua D.
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2014, 31 (01): : 16 - 21
  • [10] Persistent infection of human vascular endothelial cells by group B coxsackieviruses
    Conaldi, PG
    Serra, C
    Mossa, A
    Falcone, V
    Basolo, F
    Camussi, G
    Dolei, A
    Toniolo, A
    JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03): : 693 - 696